Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors
Advanced Malignant Solid Tumor
Shanghai Virogin Biotech Co., Ltd.30 enrolled1 locationNCT07262164
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors
Advanced Malignant Solid Tumor
Shanghai Virogin Biotech Co., Ltd.30 enrolled1 locationNCT05477849